Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip
Long-term management for leukemia is challenging due to the painful and invasive procedure of bone marrow (BM) biopsy. At present, non-invasive liquid (blood) biopsy is not utilized for leukemia, due to lower counts of leukemia blast cells in the blood. Here, we described a robust system for the sim...
Main Authors: | Khoo, Bee Luan, Shang, Menglin, Ng, Chin Hin, Lim, Chwee-Teck, Chng, Wee Joo, Han, Jongyoon |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science |
Format: | Article |
Language: | English |
Published: |
Springer
2020
|
Online Access: | https://hdl.handle.net/1721.1/128873 |
Similar Items
-
Biochip assessment of extended viability and functionality for tissue biopsies
by: Ang, Russell Way Loon
Published: (2019) -
Functionalizing the Tumor Microenvironment with Microfluidics for Anti-cancer Drug Development
by: Shang, Menglin, et al.
Published: (2019) -
Investigating the influence of physiologically relevant hydrostatic pressure on CHO cell batch culture
by: Shang, Menglin, et al.
Published: (2022) -
Microfabrication of biochip
by: Balakrishnan, Vishnuvarthan
Published: (2011) -
Minimal residual disease-guided treatment deintensilication for children with Acute Lyrnphoblastic Leukemia: results from the Malaysia-Singapore Acuten Lymphobiastic Leukemia 2003 Study
by: Yeoh, A.E.J., et al.
Published: (2012)